Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1582 USD | +2.83% | +13.88% | +13.07% |
Financials (USD)
Sales 2022 | 32.26M | Sales 2023 | 34.16M | Capitalization | 29.4M |
---|---|---|---|---|---|
Net income 2022 | 8M | Net income 2023 | 3M | EV / Sales 2022 | 0.92 x |
Net cash position 2022 | 5.75M | Net cash position 2023 | 3.94M | EV / Sales 2023 | 0.75 x |
P/E ratio 2022 |
4.73
x | P/E ratio 2023 |
9.34
x | Employees | 53 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.76% |
Latest transcript on Elite Pharmaceuticals, Inc.
1 day | +2.83% | ||
1 week | +13.88% | ||
Current month | +22.05% | ||
1 month | +28.49% | ||
3 months | +6.96% | ||
6 months | +0.83% | ||
Current year | +13.07% |
Managers | Title | Age | Since |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 13-07-31 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 09-06-30 |
Christopher Dick
PSD | President | 69 | 02-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 09-10-22 |
Barry Dash
BRD | Director/Board Member | 93 | 05-03-31 |
Davis Caskey
BRD | Director/Board Member | 76 | 16-04-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 0.1582 | +2.83% | 381 397 |
24-05-22 | 0.1539 | +2.26% | 638,141 |
24-05-21 | 0.1505 | +1.83% | 374,122 |
24-05-20 | 0.1478 | +3.36% | 889,973 |
24-05-17 | 0.143 | +2.88% | 253,804 |
Delayed Quote OTC Markets, May 23, 2024 at 01:22 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+13.07% | 164M | |
+18.71% | 44.35B | |
+19.44% | 15.08B | |
+19.49% | 14.37B | |
+57.58% | 13.06B | |
-0.05% | 6.79B | |
-9.70% | 6.75B | |
-8.87% | 5.73B | |
+13.66% | 5.64B | |
+4.00% | 4.66B |
- Stock Market
- Equities
- ELTP Stock